MedTrace Logo

Evaluation of the Metastasis and Recurrence of Prostate Cancer

NCT03507595 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-04-25

No results posted yet for this study

Summary

This study aims to use the new molecular probe 18F-PSMA for the diagnosis,staging ,recurrence monitoring and evaluation of the prostate cancer.By compared with the conventional imaging methods (whole body bone scintigraphy and MRI) and molecular imaging methods (11C-choline PET/CT),we hope to find the advantages of 18F-PSMA PET/CT in the diagnosis and metastases of prostate cancer, and lay the foundation for the further clinical transformation.

Conditions

  • Prostate Cancer (Diagnosis)
  • Prostate Cancer Metastatic
  • Prostate Cancer Recurrent
  • Prostate Cancer Stage

Sponsors & Collaborators

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Hongliang Fu, MD · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2019-10-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03507595 on ClinicalTrials.gov